Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis

被引：41
作者：
Oliver S.L. [1 ]
Yang E. [1 ]
Arvin A.M. [1 ,2 ]
机构：
[1] Department of Pediatrics, Stanford University School of Medicine, Stanford, 94305-5208, CA
[2] Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, 94305-5208, CA
来源：
Current Clinical Microbiology Reports | 2016年 / 3卷 / 4期
关键词：
Fusion; Glycoprotein; Pathogenesis; Receptor; Replication; Varicella-zoster virus;
D O I：
10.1007/s40588-016-0044-4
中图分类号：
学科分类号：
摘要：
Purpose of Review: Varicella-zoster virus (VZV), an alphaherpesvirus that causes chicken pox (varicella) and shingles (herpes zoster), is a medically important pathogen that causes considerable morbidity and, on occasion, mortality in immunocompromised patients. Herpes zoster can afflict the elderly with a debilitating condition, postherpetic neuralgia, triggering severe, untreatable pain for months or years. The lipid envelope of VZV, similar to all herpesviruses, contains numerous glycoproteins required for replication and pathogenesis. This study aims to summarize the current knowledge about VZV glycoproteins and their roles in cell entry, replication, and pathogenesis. Recent Findings: The functions for some VZV glycoproteins are known, such as gB, gH, and gL, in membrane fusion, cell-cell fusion regulation, and receptor binding properties. However, the molecular mechanisms that trigger or mediate VZV glycoproteins remain poorly understood. Summary: VZV glycoproteins are central to successful replication but their modus operandi during replication and pathogenesis remains elusive requiring further mechanistic-based studies. © 2016, Springer International Publishing AG.
引用
收藏
页码：204 / 215
页数：11
相关论文
共 100 条
[1]  
Arvin A.M., Gilden D., Varicella-zoster virus, Fields virology, 2, pp. 2015-2184, (2013)
[2]  
Zerboni L., Sen N., Oliver S.L., Arvin A.M., Molecular mechanisms of varicella zoster virus pathogenesis, Nat Rev Microbiol, 12, pp. 197-210, (2014)
[3]  
Moffat J., Ku C.C., Zerboni L., Sommer M., Arvin A., VZV: Pathogenesis and the disease consequences of primary infection, Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, (2007)
[4]  
Arvin A.M., Moffat J.F., Sommer M., Oliver S., Che X., Vleck S., Et al., Varicella-zoster virus T cell tropism and the pathogenesis of skin infection, Curr Top Microbiol Immunol, 342, pp. 189-209, (2010)
[5]  
Zerboni L., Reichelt M., Arvin A., Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts, Curr Top Microbiol Immunol, 342, pp. 255-276, (2010)
[6]  
Gilden D., Cohrs R.J., Mahalingam R., Nagel M.A., Neurological disease produced by varicella zoster virus reactivation without rash, Curr Top Microbiol Immunol, 342, pp. 243-253, (2010)
[7]  
Kost R.G., Straus S.E., Postherpetic neuralgia—pathogenesis, treatment, and prevention, N Engl J Med, 335, pp. 32-42, (1996)
[8]  
Edson C.M., Hosler B.A., Poodry C.A., Schooley R.T., Waters D.J., Thorley-Lawson D.A., Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material, Virology, 145, pp. 62-71, (1985)
[9]  
Arvin A., Campadelli-Fiume G., Mocarski E., Moore P.S., Roizman B., Whitley R., Yamanishi K., Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, (2007)
[10]  
Chouljenko D.V., Kim I.J., Chouljenko V.N., Subramanian R., Walker J.D., Kousoulas K.G., Functional hierarchy of herpes simplex virus 1 viral glycoproteins in cytoplasmic virion envelopment and egress, J Virol, 86, pp. 4262-4270, (2012)
12345678910